Jannik Buus Bertelsen

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial

Ole Norling Mathiassen, Henrik Vase, Jesper Nørgaard Bech et al. · Journal of Hypertension · 2016 · 141 citations · Full text

Medicine, Cardiology, Internal Medicine +14

The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial)

Christian D. Peters, Ole Norling Mathiassen, Henrik Vase et al. · Blood Pressure · 2017 · 26 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16

Cardiac rehabilitation after acute coronary syndrome comparing adherence and risk factor modification in a community-based shared care model versus hospital-based care in a randomised controlled trial with 12 months of follow-up

Jannik Buus Bertelsen, Jens Refsgaard, Helle Kanstrup et al. · European Journal of Cardiovascular Nursing · 2016 · 21 citations · Full text

Medicine, Cardiology, Rehabilitation Medicine +16

Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial

Morten Engholm, Jannik Buus Bertelsen, Ole Norling Mathiassen et al. · International Journal of Cardiology · 2017 · 15 citations

Medicine, Cardiology, Internal Medicine +15

Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial

Jannik Buus Bertelsen, Nasrin Tayyari Dehbarez, Jens Refsgaard et al. · Open Heart · 2018 · 12 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17